Stericycle (SRCL) Tops Q2 EPS by 2c, Beats on Revenues

August 3, 2017 4:09 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Stericycle (NASDAQ: SRCL) reported Q2 EPS of $1.15, $0.02 better than the analyst estimate of $1.13. Revenue for the quarter came in at $917.7 million versus the consensus estimate of $903.79 million.


  • Revenues of $917.7 million, an increase of 2.9%, including a 1.3% unfavorable impact from foreign exchange
  • Gross profit of $381.8 million, an increase of 1.1%
  • Reached proposed settlement of class action lawsuit of $295.0 million to reduce uncertainty and expense of continued litigation
  • Loss per share of $1.74, due primarily to the impact of the proposed class action settlement, and Adjusted earnings per share (“Adjusted EPS”) of $1.15

For earnings history and earnings-related data on Stericycle (SRCL) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities